Nordic Nanovector ASA (OSE: NANOV) ("Nordic Nanovector" or the "Company") announces the progress it has made in designing and developing a portfolio of novel and potent humanized anti-CD37...

Biomarker data demonstrates proof-of-concept for KP104's dual-targeting mechanism via dose-dependent inhibition of alternative and terminal pathways and supports intravenous and subcutaneous...

Protagonist Therapeutics (Nasdaq: PTGX) ("Protagonist" or "the Company") announced today that three abstracts related to the Company's rusfertide program have been accepted as poster presentations...

GS1 US Seeks Industry Speakers to Share Digital and Physical Supply Chain Innovation Best Practices Leveraging GS1 Standards EWING, N.J., Nov. 3, 2022 /PRNewswire/ -- GS1 US is now accepting...

Repairify's plans for upcoming training institute unveiled during 2022 SEMA press conference PLANO, Texas, Nov. 3, 2022 /PRNewswire/ -- Repairify™, Inc., a portfolio company of Kinderhook...